Andrew von Eschenbach

Andrew von Eschenbach
20th Commissioner of Food and Drugs
In office
December 13, 2006 – January 20, 2009
PresidentGeorge W. Bush
Preceded byLester Mills Crawford
Succeeded byMargaret A. Hamburg
12th Director of the National Cancer Institute
In office
January 22, 2002 – June 10, 2006
PresidentGeorge W. Bush
Preceded byRichard D. Klausner
Succeeded byJohn E. Niederhuber
Personal details
Born (1941-10-30) October 30, 1941 (age 83)
Philadelphia, Pennsylvania, U.S.
SpouseMadelyn von Eschenbach
ChildrenAndrew von Eschenbach, Amanda von Eschenbach, Warren von Eschenbach, Christian von Eschenbach
Alma materSt. Joseph's University,
Georgetown University School of Medicine

Andrew C. von Eschenbach (born October 30, 1941) was the Commissioner of the United States Food and Drug Administration from 2006 to 2009. He became acting Commissioner on September 26, 2005, after the resignation of his predecessor Lester Crawford, and was confirmed as Commissioner by the Senate on December 7, 2006.[1][2] He was previously the 12th director of the National Cancer Institute.

Von Eschenbach currently serves on the board of directors of BioTime, a biotechnology company helmed by CEO Michael D. West.[3] He also serves as a director of Viamet Pharmaceuticals.[4]

  1. ^ U.S. Congress (7 December 2006). "Executive Session". Congressional Record. 152 (134): S11404–29, S11447–51. Retrieved 2006-12-12.
  2. ^ Senate Vote No. 274
  3. ^ "BioTime, Inc. Appoints Andrew C. von Eschenbach, M.D. to its Board of Directors". BusinessWire Press Release. November 9, 2011.
  4. ^ Viamet Pharmaceuticals web site, archived from the original on 2014-06-20

Andrew von Eschenbach

Dodaje.pl - Ogłoszenia lokalne